#2259💊 Anti-Obesity Meds in RA📊 152 RA patients on semaglutide/tirzepatide 🔑 Findings💥Significant ⬇?
Tweet Content
#2259 💊 Anti-Obesity Meds in RA 📊 152 RA patients on semaglutide/tirzepatide 🔑 Findings 💥Significant ⬇️weight, BMI, ESR, CRP, lipids, pain VAS 💥Improved CVD risk ⛔ 15% GI side effects, 27% discontinued 🔎Study of impact on RA outcomes needed #ACR24 @RheumNow #ACRBest https://t.co/6LCTZl5173
Show on Archive Page
On
Display in Search Results
On
PDQ
On